AI-powered
TestTrial123
Study on Investigational Treatment for Migraine Relief
Recruiting
20 years - 70 years
Female
100 participants needed
1 Location
Brief description of study.
Cancer
Detailed description of study
Eligibility of study
You may be eligible for this study if you meet the following criteria:
- Conditions: Cancer
-
Age: 20 years - 70 years
-
Gender: Female
Updated on
19 Feb 2024.
Study ID: NCT9856
- Who can participate: Adults aged 18 to 65 who have been diagnosed with chronic migraines and have experienced at least 15 headache days per month for the past three months are eligible to participate. Participants must not have any other significant health issues that could interfere with the study.
- Study details: Participants will attend regular clinic visits where they will receive the investigational treatment or placebo. They will be required to maintain a headache diary and report any side effects. The study will include assessments of headache frequency, severity, and impact on daily activities.